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Abstract
Background: Familial Mediterranean Fever is a monogenic autoinflammatory disease, secondary to mutation of
MEFV gene, and typically expressed with recurrent attacks of fever, serositis, rash, aphthous changes in lips and/or
oral mucosa.
Kawasaki Disease, an acute systemic vasculitis with persistent fever (5 or more days), rash, stomatitis, conjunctivitis,
lymphadenopathy, changes in extremities, is currently considered a multifactorial autoinflammatory disease.
An infection, as Epstein Barr virus, can be the trigger of Kawasaki Disease.
Case presentation: We describe the clinical case of a 3-year-old boy with Kawasaki disease. Successfully treated
with intravenous immune globulin, acetyl salicylate acid, he late developed anaemia and thrombocytopenia. The
Epstein-Barr virus infection has been demonstrated and he showed a resolution of the clinical manifestations
of Kawasaki disease with the persistence of coronaritis, without aneurisms.
However, for the personal and familial history of monthly recurrent attacks of fever, pharyngitis, abdominal
pain, the genetic study of MEFV was performed and demonstrated 3 heterozygous mutations of MEFV
(E148Q, P369S, R408Q).
Conclusions: Mutations of MEFV can contribute to increase inflammatory expression in other diseases, as
Kawasaki disease.
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Background
Familial Mediterranean Fever (FMF) is a monogenic
autoinflammatory disease, secondary to mutations of
MEFV gene, typically expressed with recurrent attacks of
fever, serositis, rash, aphthous changes in lips and/or
oral mucosa [1, 2]. FMF is caused by dysregulation of
the inflammasome, a complex intracellular multiprotein
structure, commanding the overproduction of
interleukin-1(IL-1). The attacks of FMF can recognize a
trigger in infections, stress, menses.
Kawasaki Disease (KD), an acute systemic vasculitis
with persistent fever (5 or more days), rash, stomatitis,
conjunctivitis, lymphadenopathy, changes in extremities
(oedema and/or rash of souls and palms), is currently
considered a multifactorial autoinflammatory disease [3].
Although the aetiological mechanism of KD remains
unknown, recent studies support the hypothesis that a
dysregulation of the immune response to infectious
triggers is a possible contribution to KD pathogenesis.
Furthermore, superantigens are proteins, which can
activate T cells in the peripheral blood, inducing these
cells to form a bridge between the T-cell receptor and
the major histocompatibility complex class II of antigen
presenting cells in the absence of any antigenic peptide
presentation. This outcomes in the overproduction of
pro-inflammatory cytokines.
Based on serological and polymerase chain reaction
(PCR) analyses of clinical specimens, at least 14 species
of virus have been reported to be associated with KD, as
Parvovirus, Epstein-Barr virus (EBV), Adenovirus, with a
different geographic distribution of the disease [3].
Patients with KD show risk loci and polymorphisms
identified by genome wide association studies. Genetic
polymorphisms associated with KD susceptibility and
resistance to IVIG therapy are documented in the gene
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encoding inositol-triphosphate 3-kinase C (ITPKC) [4],
in the CASP3 gene [5], in the gene encoding ORAI1, a
calcium release-activated calcium channel protein 1,
with a possible influence on the immune response to
EBV infection [6].
Some studies indicate that KD could be associated
with dysregulated innate immune response. Its inad-
equate regulation rises inflammatory tissue damage and
increases the inflammatory response.
In a KD mouse model, myocarditis, coronary artery
vasculitis and aortitis are induced with an injection of a cell
wall extract from Lactobacillus casei. The mice manifest
increased body temperature, systemic inflammation, asso-
ciated with elevated levels of IL-1β. In addition, IL-1 re-
lated genes are upregulated in KD peripheral blood during
acute phase of illness [7]. Studies in the Lactobacillus
casei-induced mouse model of KD showed that the NLRP3
inflammasome, caspase 1 activation, IL-1β and IL-1α are
involved in KD vasculitis.
The polymorphisms of the ITPKC gene were signifi-
cantly associated with KD in Japan and US [4].
Notably, the ITPKC regulates intracellular Ca2+ in-
flux and the mutation of the kinase leads to increased
intracellular Ca2+, which induces NLRP3 inflamma-
some activation [8].
Furthermore, some studies evaluated the benefits of
IL-1 blockade with anakinra, obtaining a reduction in
inflammation.
IL-1Ra pre-treatment significantly reduced KD-induced
myocardial inflammation and N-terminal pro B-type natri-
uretic peptide release, improved ejection fraction and a
normalized left ventricular function, Lactobacillus casei-in-
duced mouse model of KD. These data support the prom-
ising beneficial effects of IL-1Ra therapy in preventing the
complications (myocarditis and myocardial dysfunction,
coronaritis) in the acute phase of KD [9].
The central role of IL-1 in KD pathogenesis, supports
the consideration that KD can be considered as a multi-
factorial autoinflammatory disease.
Many clinical features of KD are similar to those de-
scribed in systemic autoinflammatory diseases (SAID),
including systemic-onset juvenile idiopathic arthritis
(SoJIA): sudden and seemingly unprovoked onset of
fever, skin rash, eye and mouth inflammation, cervical
adenitis, serositis, pericarditis. Marked elevation of acute
phase reactants, high platelets and neutrophils count,
anaemia, hypoalbuminemia are common in KD and in
soJIA. Intriguingly, transient coronary abnormalities
have also been documented in patients with soJIA [10].
KD patients are treated with intravenous immune
globulins (IVIG) (2 g/kg) and acetyl salicylate acid (ASA)
(30–50mg/kg/day); lowered to 3–5 mg/kg/day at when
afebrile for 48–72 h. In non-responders to IVIG, in pa-
tients with a severe outcome or high risk of coronaritis,
a second step treatment is required, with high doses of
steroids, anti-IL-1 biologic drugs, with documented
safety profile in children [11] and immune suppressive
drugs [12, 13].
Recent studies support the critical role for IL-1 β in
the pathogenesis of SAID and KD. Furthermore, IL-1
polymorphisms could be associated with response or
resistance to IVIG. Interestingly elevated transcripts have
been shown in IVIG-resistant KD patients, those carry-
ing the highest risk for coronary aneurysms [14, 15].
Case presentation
We report on a 3-year-old boy with fever persisting for 6
days, non-secretive conjunctivitis, lymphadenitis of the neck,
generalized, fixed rash, more expressed in the perineal Xre-
gion. He presented hepatosplenomegaly, gallbladder hydrops,
neutrophil leucocytosis, hyponatraemia (128mEq/l), hypoal-
buminemia, significant increase of C-reactive protein (CRP)
13mg/dl; erythrocyte sedimentation rate (ESR): 57; D-dimer.
836 ng/ml; AST, ALT, gamma-GT (1.5 x n.v.). Abdominal
ultrasound documented hepatosplenomegaly with an aspect
of “starry sky liver”.
Incomplete KD was the diagnosis of the child and he re-
ceived IVIG (2 g/kg) and ASA (50mg/kg/day). Fever resolved
12 h after the IVIG infusion. However, he showed anaemia
(8 g/dl), thrombocytopenia (78.000/mm3), with a reduction
and normalization of CRP and leukocytes number.
Echocardiographic study evidenced coronaritis without
aneurisms.
Serology for Epstein-Barr Virus (EBV) was detected
before IVIG infusion (for fever with cholestatic hepatitis
and the skin rash [16]), and showed a positive IgM EBV-
VCA (78,3 UI/ml), confirmed by PCR for EBV.
13 days after the onset of the fever he showed thrombo-
cytosis (687.000/mm3) and, the day after, he presented
perineal and subungual desquamation.
Moreover, familial anamnesis reported recurrent epi-
sodes of fever with pharyngitis and undefined nephropa-
thy in the grandmother; recurrent episodes of fever,
pharyngitis, abdominal pain every month in the child
and in the father.
The genetic study for FMF, TNF receptor-associated
periodic syndrome (TRAPS), Mevalonate kinase defi-
ciency (MVK) documented the presence of the MEFV
gene heterozygous mutations E148Q (exon 2), P369S,
R408Q (exon 3) in the child, in the sibling, in the 6-
years-old brother and in the father. All the subjects
studied showed increased levels of serum amyloid A
(SAA) (> 5–10 x n.v.) far away from recurrent attacks.
Discussion and conclusions
The conjunction of genetic data with the demonstrated
crucial role of IL-1 signature in the experimental mouse
model of KD, as well as the upregulation of IL-1
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pathway in KD patients, strongly supports the hypothesis
that IL-1 pathway plays a key role in KD vasculitis and
coronary arteritis.
The association of FMF and KD has been reported in
some studies. Clinical and immunological relationships
between KD and FMF further support the hypothesis
that KD must be considered as an autoinflammatory
disease. New insights regarding the pathogenesis of KD
revealed the key role of IL-1 signalling in the pathogen-
esis of KD and of other vasculitis. MEFV mutations are
associated with increased risk of vasculitis, as Henoch-
Schöenlein purpura and KD. However, MEFV mutations
are underdiagnosed in some geographical areas as in Sicily,
were KD has a relative high incidence of coronaritis [17].
A study on 138 children affected by KD did not show
an increased risk of KD and/or associated coronaritis
among the patients with MEFV mutations, as E148Q,
P369S, R408Q [18].
However, other studies demonstrated that MEFV muta-
tions can be a risk factor of increased inflammatory expres-
sion in other diseases, as soJIA, Bechet disease, recurrent
pericarditis, systemic vasculitis, with the proposed defin-
ition of “pyrin-associated disorders” [19, 20].
In our case, the association of the 3 mutations, rarely
described in the same patient, could be the amplifying
factor of a meaningful clinical picture, expressed as in-
complete KD and triggered by an infection, as possible
trigger both in FMF attacks and in KD [21].
In our patient, the resolution of symptoms and biochem-
ical alterations secondary to KD significantly improved
after IVIG infusion. However, EBV infection was the cause
of late anaemia and thrombocytopenia, trigger of the KD
and reason of the peculiar clinical picture.
The critical role for IL-1 β in the pathogenesis of KD cre-
ate a bridge between KD and SAID, as FMF, explaining the
pathogenetic role of MEFV mutations in the described case.
Further studies are necessary to clarify the possible
link between a dysregulation of innate immune response
to infections, monogenic SAID and KD: the interpret-
ation of KD as a multifactorial autoinflammatory disease
contributes to a new treat-to-target approach.
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